Hospital Angeles Leads the Clinical Trial Investigating the Safety & Efficacy of NKMax’s SNK01 in Patients with Plaque Psoriasis

Hospital Angeles Leads the Clinical Trial Investigating the Safety & Efficacy of NKMax’s SNK01 in Patients with Plaque Psoriasis

Aug 22, 2019 | Autologous Natural Killer Cell, Cell Therapy, Hospital Angeles, Mexico, Natural Killer Cells, Psoriasis

Angeles Hospital, a private state-of-the-art hospital in Tijuana, Mexico is conducting a clinical trial on behalf of Irvine, CA biotech sponsor NKMax America (part of Korean Parent) and just announced it treated the first participant in the study of SNK01-MX03, a...

Pin It on Pinterest